DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $19,271,000 | -28.7% | 2,805,045 | 0.0% | 0.51% | -12.9% |
Q1 2022 | $27,041,000 | -18.9% | 2,805,045 | 0.0% | 0.59% | +0.3% |
Q4 2021 | $33,352,000 | -26.8% | 2,805,045 | 0.0% | 0.59% | -6.8% |
Q3 2021 | $45,554,000 | -22.8% | 2,805,045 | 0.0% | 0.63% | -33.4% |
Q2 2021 | $59,018,000 | +35.5% | 2,805,045 | 0.0% | 0.95% | +44.1% |
Q1 2021 | $43,562,000 | -26.0% | 2,805,045 | 0.0% | 0.66% | -20.2% |
Q4 2020 | $58,906,000 | +4.0% | 2,805,045 | 0.0% | 0.82% | -20.6% |
Q3 2020 | $56,634,000 | – | 2,805,045 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |